These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2150190)
1. Renal effects of the new calcium channel blocking drug isradipine. Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects. Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658 [TBL] [Abstract][Full Text] [Related]
4. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans. Sørensen SS; Jensen JD; Madsen JK; Pedersen EB Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922 [TBL] [Abstract][Full Text] [Related]
5. Effects of long-term administration of isradipine on renal hemodynamics and sodium metabolism. Francischetti EA; Barroso I; da Silva A; Fagundes VG J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S90-2. PubMed ID: 1376847 [TBL] [Abstract][Full Text] [Related]
6. Long-term effects of isradipine on blood pressure and renal function. Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650 [TBL] [Abstract][Full Text] [Related]
7. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy. Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765 [TBL] [Abstract][Full Text] [Related]
8. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension. Persson B; Wysocki M; Andersson OK J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710 [TBL] [Abstract][Full Text] [Related]
9. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects. Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655 [TBL] [Abstract][Full Text] [Related]
10. Effects of isradipine on hypertension and renal hemodynamics. Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846 [TBL] [Abstract][Full Text] [Related]
11. Renal and hemodynamic effects of isradipine in essential hypertension. Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657 [TBL] [Abstract][Full Text] [Related]
12. The calcium antagonist isradipine and its effect on blood pressure related to plasma renin activity. Carr AA; Prisant LM Am J Hypertens; 1990 May; 3(5 Pt 1):354-9. PubMed ID: 2140943 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity. Allikmets K; Parik T; Teesalu R Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of isradipine in essential hypertension. Grossman E; Messerli FH; Oren S; Nunez B; Garavaglia GE Am J Cardiol; 1991 Jul; 68(1):65-70. PubMed ID: 1829320 [TBL] [Abstract][Full Text] [Related]
15. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals. Nagao T; Yamaguchi I; Narita H; Nakajima H Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men. Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578 [TBL] [Abstract][Full Text] [Related]
17. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383 [TBL] [Abstract][Full Text] [Related]
18. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease. Kloke HJ; Wetzels JF; Koene RA; Huysmans FT Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641 [TBL] [Abstract][Full Text] [Related]
19. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function. Wittenberg C; Rosenfeld JB Am J Hypertens; 1991 Feb; 4(2 Pt 2):191S-193S. PubMed ID: 1827019 [TBL] [Abstract][Full Text] [Related]
20. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria. Persson B; Andersson OK; Wysocki M; Hedner T; Karlberg B J Intern Med; 1992 Mar; 231(3):247-52. PubMed ID: 1532613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]